These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27744658)

  • 21. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
    Boland JM; Maleszewski JJ; Wampfler JA; Voss JS; Kipp BR; Yang P; Yi ES
    Hum Pathol; 2018 Jan; 71():8-19. PubMed ID: 28823574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.
    Tsubokawa N; Mimae T; Miyata Y; Sasada S; Yoshiya T; Kushitani K; Takeshima Y; Murakami S; Yokose T; Ito H; Nakayama H; Okada M
    Jpn J Clin Oncol; 2016 Nov; 46(11):1015-1021. PubMed ID: 27566971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lung.
    Saito T; Tsuta K; Honda O; Ishida M; Yamaka R; Tanaka N; Ishida K; Utsumi T; Maru N; Matsui H; Taniguchi Y; Hino H; Kurata T; Murakawa T
    Lung Cancer; 2020 Aug; 146():50-57. PubMed ID: 32512273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas.
    Zhang H; Lu C; Lu Y; Yu B; Lv F; Zhu Z
    Onco Targets Ther; 2016; 9():2337-48. PubMed ID: 27143929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
    Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
    J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low papillary structure in lepidic growth component of lung adenocarcinoma: a unique histologic hallmark of aggressive behavior.
    Fukutomi T; Hayashi Y; Emoto K; Kamiya K; Kohno M; Sakamoto M
    Hum Pathol; 2013 Sep; 44(9):1849-58. PubMed ID: 23648380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maspin expression patterns differ in the invasive versus lepidic growth pattern of pulmonary adenocarcinoma.
    Lonardo F; Guan H; Dzinic S; Sheng S
    Histopathology; 2014 Dec; 65(6):757-63. PubMed ID: 25040445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the size of the lepidic component negligible when measuring the size of the tumor to determine the stage of lung adenocarcinoma?
    Moon Y
    J Thorac Dis; 2021 Mar; 13(3):1434-1444. PubMed ID: 33841936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.
    Katsumata S; Aokage K; Miyoshi T; Tane K; Nakamura H; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Hayashi R; Tsuboi M; Ishii G
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1679-1688.e2. PubMed ID: 30257286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm.
    Luzzi L; Marulli G; DE Palma A; Meniconi F; Ghisalberti M; Stocca F; Pagliarulo V; Loizzi M; Rea F; Gotti G
    Minerva Chir; 2016 Feb; 71(1):1-7. PubMed ID: 26149520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenocarcinoma classification: patterns and prognosis.
    Kuhn E; Morbini P; Cancellieri A; Damiani S; Cavazza A; Comin CE
    Pathologica; 2018 Mar; 110(1):5-11. PubMed ID: 30259909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201.
    Tsutani Y; Suzuki K; Koike T; Wakabayashi M; Mizutani T; Aokage K; Saji H; Nakagawa K; Zenke Y; Takamochi K; Ito H; Aoki T; Okami J; Yoshioka H; Okada M; Watanabe SI;
    Ann Thorac Surg; 2019 Nov; 108(5):1484-1490. PubMed ID: 31336067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis.
    Boland JM; Wampfler JA; Yang P; Yi ES
    Lung Cancer; 2017 Jul; 109():14-20. PubMed ID: 28577944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
    Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
    Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Margin Width of Resected Lepidic Lung Cancer Does Not Affect Recurrence After Sublobar Resection.
    Moon Y; Lee KY; Park JK
    World J Surg; 2018 May; 42(5):1449-1457. PubMed ID: 29043409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction.
    Yeh YC; Wu YC; Chen CY; Wang LS; Hsu WH; Chou TY
    J Clin Pathol; 2012 Oct; 65(10):910-8. PubMed ID: 22813729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung.
    Kato F; Hamasaki M; Miyake Y; Iwasaki A; Iwasaki H; Nabeshima K
    Lung Cancer; 2012 Sep; 77(3):495-500. PubMed ID: 22727683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
    Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.